Have a feature idea you'd love to see implemented?
Let us know!
KRRO Korro Bio Inc.
Price (delayed)
$37.01
Market cap
$346.72M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.95
Enterprise value
$323.53M
frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the
Highlights
KRRO's EPS has soared by 99% YoY and by 97% QoQ
KRRO's quick ratio has surged by 140% year-on-year but it is down by 15% since the previous quarter
KRRO's net income has dropped by 105% year-on-year and by 2.5% since the previous quarter
Korro Bio's equity has decreased by 9% from the previous quarter
Key stats
What are the main financial stats of KRRO
Market
Valuations
Earnings
Shares outstanding
9.37M
Market cap
$346.72M
Enterprise value
$323.53M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.92
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Net income
-$101.6M
EBIT
-$100.53M
EBITDA
-$91.62M
Free cash flow
-$116.75M
Per share
Balance sheet
Liquidity
EPS
-$1.95
EPS diluted
-$1.95
Free cash flow per share
-$12.55
Book value per share
$19.32
Revenue per share
$0
TBVPS
$26.18
Total assets
$243.54M
Total liabilities
$63.91M
Debt
$41.79M
Equity
$179.63M
Working capital
$139.17M
Debt to equity
0.23
Current ratio
11.23
Quick ratio
10.93
Net debt/EBITDA
0.25
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-44.5%
Return on equity
-58.1%
Return on invested capital
-75.1%
Return on capital employed
-43.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
KRRO stock price
How has the Korro Bio stock price performed over time
Intraday
-2.99%
1 week
-3.54%
1 month
-21.05%
1 year
-20.75%
YTD
-2.78%
QTD
-2.78%
Financial performance
How have Korro Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$108.4M
Net income
-$101.6M
Gross margin
N/A
Net margin
N/A
KRRO's operating income has dropped by 109% year-on-year and by 4% since the previous quarter
KRRO's net income has dropped by 105% year-on-year and by 2.5% since the previous quarter
Growth
What is Korro Bio's growth rate over time
Valuation
What is Korro Bio stock price valuation
P/E
N/A
P/B
1.92
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
KRRO's EPS has soared by 99% YoY and by 97% QoQ
The stock's price to book (P/B) is 26% less than its last 4 quarters average of 2.6 and 9% less than its 5-year quarterly average of 2.1
Korro Bio's equity has decreased by 9% from the previous quarter
Efficiency
How efficient is Korro Bio business performance
The return on equity has surged by 89% year-on-year and by 19% since the previous quarter
KRRO's ROIC is up by 39% YoY and by 38% from the previous quarter
KRRO's return on assets is up by 32% year-on-year and by 20% since the previous quarter
Dividends
What is KRRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for KRRO.
Financial health
How did Korro Bio financials performed over time
The current ratio has soared by 154% YoY but it has contracted by 15% from the previous quarter
KRRO's quick ratio has surged by 140% year-on-year but it is down by 15% since the previous quarter
Korro Bio's debt is 77% less than its equity
KRRO's debt to equity is up by 21% since the previous quarter
Korro Bio's equity has decreased by 9% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.